BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19845494)

  • 1. P2X7-mediated chemoprevention of epithelial cancers.
    Gorodeski GI
    Expert Opin Ther Targets; 2009 Nov; 13(11):1313-32. PubMed ID: 19845494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of apoptosis pathways in cancer.
    Ziegler DS; Kung AL
    Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells.
    Bulanova E; Budagian V; Orinska Z; Koch-Nolte F; Haag F; Bulfone-Paus S
    J Leukoc Biol; 2009 Apr; 85(4):692-702. PubMed ID: 19164130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P2X7 receptor: a novel biomarker of uterine epithelial cancers.
    Li X; Zhou L; Feng YH; Abdul-Karim FW; Gorodeski GI
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1906-13. PubMed ID: 17035398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration.
    Díaz-Hernández M; Díez-Zaera M; Sánchez-Nogueiro J; Gómez-Villafuertes R; Canals JM; Alberch J; Miras-Portugal MT; Lucas JJ
    FASEB J; 2009 Jun; 23(6):1893-906. PubMed ID: 19171786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis.
    Turner CM; Tam FW; Lai PC; Tarzi RM; Burnstock G; Pusey CD; Cook HT; Unwin RJ
    Nephrol Dial Transplant; 2007 Feb; 22(2):386-95. PubMed ID: 17040997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine.
    Doná F; Ulrich H; Persike DS; Conceição IM; Blini JP; Cavalheiro EA; Fernandes MJ
    Epilepsy Res; 2009 Feb; 83(2-3):157-67. PubMed ID: 19084381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenously expressed truncated P2X7 receptor lacking the C-terminus is preferentially upregulated in epithelial cancer cells and fails to mediate ligand-induced pore formation and apoptosis.
    Feng YH; Li X; Zeng R; Gorodeski GI
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1271-6. PubMed ID: 17065105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIP(2) regulates the ionic current of P2X receptors and P2X(7) receptor-mediated cell death.
    Zhao Q; Yang M; Ting AT; Logothetis DE
    Channels (Austin); 2007; 1(1):46-55. PubMed ID: 19151591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The P2X7 ATP receptor modulates renal cyst development in vitro.
    Hillman KA; Woolf AS; Johnson TM; Wade A; Unwin RJ; Winyard PJ
    Biochem Biophys Res Commun; 2004 Sep; 322(2):434-9. PubMed ID: 15325248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2X7 receptor antagonism in the treatment of cancers.
    Roger S; Pelegrin P
    Expert Opin Investig Drugs; 2011 Jul; 20(7):875-80. PubMed ID: 21619470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
    Donnelly-Roberts DL; Jarvis MF
    Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.
    Michel AD; Fonfria E
    Br J Pharmacol; 2007 Oct; 152(4):523-37. PubMed ID: 17700717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging concepts in targeting the polyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapy.
    Basuroy UK; Gerner EW
    J Biochem; 2006 Jan; 139(1):27-33. PubMed ID: 16428316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of peripheral adenosine 5'-triphosphate and P2X purinoceptor in pain-related behavior produced by orthotopic melanoma inoculation in mice.
    Fujita M; Andoh T; Sasaki A; Saiki I; Kuraishi Y
    Eur J Neurosci; 2010 May; 31(9):1629-36. PubMed ID: 20525075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical allodynia and spinal up-regulation of P2X4 receptor in experimental autoimmune neuritis rats.
    Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
    Neuroscience; 2008 Mar; 152(2):495-501. PubMed ID: 18276080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X7 and phospholipid signalling: the search of the "missing link" in epithelial cells.
    Garcia-Marcos M; Pochet S; Marino A; Dehaye JP
    Cell Signal; 2006 Dec; 18(12):2098-104. PubMed ID: 16815675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
    Aziz MH; Reagan-Shaw S; Wu J; Longley BJ; Ahmad N
    FASEB J; 2005 Jul; 19(9):1193-5. PubMed ID: 15837718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.